Prospective studies are advantageous over retrospective studies since blood samples to measure IGF‐1 levels are collected before the clinical diagnosis of cancer and hence reverse causation (i.e., effects of an undiagnosed cancer on levels of IGF‐1) is less likely to play a role 50. Here, IGF1 is linked to cancer.